[ACRX] YoY Quarter Result on 31-Mar-2017 [#Q1]

Stock
[ACRX] AcelRx Pharmaceuticals, Inc.
Announcement Date
08-May-2017
Financial Year
2017
Quarter
31-Mar-2017 [#Q1]
Profit Trend
QoQ- -60.62%
YoY- -41.62%
Quarter Report
ACRX's Result
ACRX's Financial Summary
View:
Show?
Quarter Result
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
Revenue 386 265 343 3,109 3,025 181 95 26.29%
PBT -15,925 -13,674 -11,592 -15,551 -10,979 -10,026 -9,631 8.73%
Tax 843 627 136 -2,704 2 806 -618 -
NP -15,925 -13,674 -11,592 -15,551 -10,981 -10,026 -9,631 8.73%
Tax Rate - - - - - - - -
Total Cost 16,311 13,939 11,935 18,660 14,006 10,207 9,726 8.99%
Ratio Analysis
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
NP Margin -4,125.65 -5,160.00 -3,379.59 -500.19 -363.01 -5,539.23 -10,137.89 -13.90%
Per Share
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
EPS -3.98 -3.47 -4.55 -6.86 -4.85 -4.57 -4.46 -1.87%
EPS Diluted -3.98 -3.47 -4.55 -6.86 -4.85 -4.51 -4.46 -1.87%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.